35 min

Taking the Waiting Around Out of Inpatient Rounds with Mike Pitt of Q-rounds Constant Variables

    • Technology

How does a research project turn into a company with a story to sell? When “How does this not already exist?” is the overwhelming response to the idea.
CEO Mike Pitt shares the obvious need behind the development of Q-rounds, the complications around testing a product intended for hospital use, and why he hasn’t accepted the entrepreneur label.
SHOW LINKS
Email Mike Pitt | mike@q-rounds.com
Q-rounds.com | https://q-rounds.com/ 
Q-rounds on LinkedIn | https://www.linkedin.com/company/q-rounds 
Michael Roth on LinkedIn | https://www.linkedin.com/in/michael-roth-508772183/ 
Follow The Jed Mahonis Group on LinkedIn | https://linkedin.com/company/the-jed-mahonis-group 
Learn more about The Jed Mahonis Group | https://jmg.mn

How does a research project turn into a company with a story to sell? When “How does this not already exist?” is the overwhelming response to the idea.
CEO Mike Pitt shares the obvious need behind the development of Q-rounds, the complications around testing a product intended for hospital use, and why he hasn’t accepted the entrepreneur label.
SHOW LINKS
Email Mike Pitt | mike@q-rounds.com
Q-rounds.com | https://q-rounds.com/ 
Q-rounds on LinkedIn | https://www.linkedin.com/company/q-rounds 
Michael Roth on LinkedIn | https://www.linkedin.com/in/michael-roth-508772183/ 
Follow The Jed Mahonis Group on LinkedIn | https://linkedin.com/company/the-jed-mahonis-group 
Learn more about The Jed Mahonis Group | https://jmg.mn

35 min

Top Podcasts In Technology

No Priors: Artificial Intelligence | Technology | Startups
Conviction | Pod People
Lex Fridman Podcast
Lex Fridman
All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
Hard Fork
The New York Times
Acquired
Ben Gilbert and David Rosenthal
The Neuron: AI Explained
The Neuron